Reuters exclusively reports AstraZeneca gets partial immunity in low-cost EU vaccine deal

Reuters exclusively reported that European governments will pay claims above an agreed limit against AstraZeneca over side effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi. The deals reflect different strategies by two of the world’s top drugmakers for protecting themselves as a debate rages about liabilities for vaccines aimed at ending the pandemic. 

Article Tags
Topics of Interest: Health
Type: Reuters Best
Regions: Europe
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
Sign up for email updates

Sign up for email updates